Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 1061-1066

  Collins, L C ^a,e   Marotti, J D ^b,c   Gelber, S ^d   Cole, K ^f   Ruddy, K ^d,e   Kereakoglow, S ^d   Brachtel, E F ^e,g   Schapira, L ^e,g   Come, S E ^a,e   Winer, E P ^d,e   Partridge, A H ^d,e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f METROWEST MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Luminal B; Molecular phenotypes; Prognosis; Young women

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CANCER GRADING; CANCER INVASION; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 84856211697     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1872-9     Document Type: Article

References (35)

1. ER Fisher S Anderson E Tan-Chiu B Fisher L Eaton N Wolmark 2001 Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06 Cancer 91 8 Suppl 1679 1687 11309768 10.1002/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0. CO;2-8 1:STN:280:DC%2BD3M3hvFWnsw%3D%3D
2. C Gajdos PI Tartter IJ Bleiweiss C Bodian ST Brower 2000 Stage 0 to stage III breast cancer in young women J Am Coll Surg 190 5 523 529 10801018 10.1016/S1072-7515(00)00257-X 1:STN:280:DC%2BD3c3lvV2mtA%3D%3D
3. W Han SW Kim IA Park D Kang YK Youn SK Oh, et al. 2004 Young age: an independent risk factor for disease-free survival in women with operable breast cancer BMC Cancer 4 82 15546499 10.1186/1471-2407-4-82
4. N Kroman MB Jensen J Wohlfahrt HT Mouridsen PK Andersen M Melbye 2000 Factors influencing the effect of age on prognosis in breast cancer: population based study BMJ 320 7233 474 478 10678859 10.1136/bmj.320.7233.474 1:STN:280:DC%2BD3c7ktlKitw%3D%3D
5. E Rapiti G Fioretta HM Verkooijen G Vlastos P Schafer AP Sappino, et al. 2005 Survival of young and older breast cancer patients in Geneva from 1990 to 2001 Eur J Cancer 41 10 1446 1452 15919199 10.1016/j.ejca.2005.02.029
6. HO Adami B Malker L Holmberg I Persson B Stone 1986 The relation between survival and age at diagnosis in breast cancer N Engl J Med 315 9 559 563 3736639 10.1056/NEJM198608283150906 1:STN:280:DyaL283osV2isg%3D%3D
7. CK Anders DS Hsu G Broadwater CR Acharya JA Foekens Y Zhang, et al. 2008 Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression J Clin Oncol 26 20 3324 3330 18612148 10.1200/JCO.2007.14.2471
8. SH Ahn BH Son SW Kim SI Kim J Jeong SS Ko, et al. 2007 Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-a report from the Korean Breast Cancer Society J Clin Oncol 25 17 2360 2368 17515570 10.1200/JCO.2006.10.3754
9. M Colleoni N Rotmensz C Robertson L Orlando G Viale G Renne, et al. 2002 Very young women (<35 years) with operable breast cancer: features of disease at presentation Ann Oncol 13 2 273 279 11886005 10.1093/annonc/mdf039 1:STN:280:DC%2BD387ltl2gtw%3D%3D
10. CK Anders C Fan JS Parker LA Carey KL Blackwell N Klauber-DeMore, et al. 2011 Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 29 1 e18 e20 21115855 10.1200/JCO.2010.28.9199
11. CM Perou SS Jeffrey M van de Rijn CA Rees MB Eisen DT Ross, et al. 1999 Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci USA 96 16 9212 9217 10430922 10.1073/pnas.96.16.9212 1:CAS:528:DyaK1MXltVequro%3D
12. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D
13. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 14 8418 8423 12829800 10.1073/pnas. 0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D
14. JD Brenton LA Carey AA Ahmed C Caldas 2005 Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol 23 29 7350 7360 16145060 10.1200/JCO.2005.03.3845 1:CAS:528: DC%2BD2MXhtF2nsLrJ
15. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees, et al. 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
16. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Jama 295 21 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528: DC%2BD28XlsV2rtLw%3D
17. FM Carvalho LM Bacchi PP Santos CE Bacchi 2010 Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients Clinics (Sao Paulo) 65 10 1033 1036 10.1590/S1807-59322010001000019
18. IV-CR Alvarado-Cabrero S Barroso-Bravo 2011 Breast cancer in Mexican women younger than age 45 years. A clinicopathologic study of 1, 320 cases Mod Pathol 24 26A 10.1038/modpathol.2010.158
19. R Epstein 1992 Analysis of natural history of breast cancer in young women Lancet 340 8830 1287 1359337 10.1016/0140-6736(92)92985-O 1:STN:280:DyaK3s%2FmtFKlsA%3D%3D
20. LJ Solin B Fowble DJ Schultz RL Goodman 1989 Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer Int J Radiat Oncol Biol Phys 16 2 373 381 2537806 10.1016/0360-3016(89)90333-7 1:STN:280:DyaL1M7lsFahtw%3D%3D
21. KN Ogston ID Miller S Payne AW Hutcheon TK Sarkar I Smith, et al. 2003 A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival Breast 12 5 320 327 14659147 10.1016/S0960-9776(03)00106-1
22. MC Cheang D Voduc C Bajdik S Leung S McKinney SK Chia, et al. 2008 Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 5 1368 1376 18316557 10.1158/1078-0432.CCR-07-1658 1:CAS:528:DC%2BD1cXislSrs7o%3D
23. MCU Cheang SK Chia D Voduc D Gao S Leung J Snider M Watson S Davies PS Bernard JS Parker CM Perous MJ Ellis TO Nielsen 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 10 736 750 19436038 10.1093/jnci/djp082 1:CAS:528:DC%2BD1MXmtlyit74%3D
24. RM Tamimi HJ Baer J Marotti M Galan L Galaburda Y Fu, et al. 2008 Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer Breast Cancer Res 10 4 R67 18681955 10.1186/bcr2128
25. XR Yang ME Sherman DL Rimm J Lissowska LA Brinton B Peplonska, et al. 2007 Differences in risk factors for breast cancer molecular subtypes in a population-based study Cancer Epidemiol Biomarkers Prev 16 3 439 443 17372238 10.1158/1055-9965.EPI-06-0806 1:CAS:528:DC%2BD2sXjt1Srt7s%3D
26. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 16 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D
27. MA Maggard JB O'Connell KE Lane JH Liu DA Etzioni CY Ko 2003 Do young breast cancer patients have worse outcomes? J Surg Res 113 1 109 113 12943818 10.1016/S0022-4804(03)00179-3
28. KM O'Brien SR Cole CK Tse CM Perou LA Carey WD Foulkes, et al. 2010 Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study Clin Cancer Res 16 24 6100 6110 21169259 10.1158/1078-0432.CCR-10-1533
29. A Caldarella E Crocetti S Bianchi V Vezzosi C Urso M Biancalani, et al. 2011 Female breast cancer status according to ER, PR and HER2 expression: a population based analysis Pathol Oncol Res 17 3 753 758 21479875 10.1007/s12253-011-9381-z 1:CAS:528:DC%2BC3MXhtVKltrvI
30. Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G, Cancello G, et al. (2011) Breast cancer subtypes and outcome after local and regional relapse. Ann Oncol. doi: 10.1093/annonc/mdr129
31. LM Bacchi M Corpa PP Santos CE Bacchi FM Carvalho 2010 Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: a pathological and immunohistochemical study Breast 19 2 137 141 20117934 10.1016/j.breast.2010.01.002 1:STN:280:DC%2BC3c3ltVCrsQ%3D%3D
32. CA Livasy G Karaca R Nanda MS Tretiakova OI Olopade DT Moore, et al. 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 2 264 271 16341146 10.1038/modpathol.3800528 1:CAS:528: DC%2BD28Xlt1eqtw%3D%3D
33. EA Rakha ME El-Sayed AR Green AH Lee JF Robertson IO Ellis 2007 Prognostic markers in triple-negative breast cancer Cancer 109 1 25 32 17146782 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D
34. R Dent M Trudeau KI Pritchard WM Hanna HK Kahn CA Sawka, et al. 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 15 Pt 1 4429 4434 17671126 10.1158/1078-0432.CCR-06-3045
35. LC Collins JD Marotti HJ Baer RM Tamimi 2008 Comparison of estrogen receptor results from pathology reports with results from central laboratory testing J Natl Cancer Inst 100 3 218 221 18230800 10.1093/jnci/djm270 1:CAS:528:DC%2BD1cXivFygs70%3D